Serge Christmann‐Franck

Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound–Kinase Activities: A Way toward Selective Promiscuity by Design?

Serge Christmann‐Franck, Gerard J. P. van Westen, George Papadatos et al. · Journal of Chemical Information and Modeling · 2016 · 61 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Discovery and structure-guided drug design of inhibitors of 11β-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold

Franck Lepifre, Serge Christmann‐Franck, Didier Roche et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Structure-Based Virtual Screening:  An Application to Human Topoisomerase II α

Serge Christmann‐Franck, Hugues‐Olivier Bertrand, Anne Lamy et al. · Journal of Medicinal Chemistry · 2004 · 26 citations

Pharmacy, Biochemistry, Medicinal Chemistry +17

Discovery and structure–activity relationships of pentanedioic acid diamides as potent inhibitors of 11β-hydroxysteroid dehydrogenase type I

Didier Roche, Denis Carniato, Caroline Leriche et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Structure-based design of 7-azaindole-pyrrolidine amides as inhibitors of 11β-hydroxysteroid dehydrogenase type I

Eric Valeur, Serge Christmann‐Franck, Franck Lepifre et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 12 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13